CLB
Core Laboratories N.V.

904
Mkt Cap
$770.57M
Volume
183,382.00
52W High
$20.82
52W Low
$9.72
PE Ratio
23.86
CLB Fundamentals
Price
$16.58
Prev Close
$16.48
Open
$16.65
50D MA
$14.65
Beta
1.28
Avg. Volume
497,057.32
EPS (Annual)
$0.6695
P/B
2.80
Rev/Employee
$149,670.86
Loading...
Loading...
News
all
press releases
Gendell Jeffrey L Has $6.56 Million Holdings in Core Laboratories Inc. $CLB
Gendell Jeffrey L lifted its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 24.6% in the 2nd quarter, according to the company in its most recent filing with the SEC. The...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now
CLB benefits from long-term industry investments and strong acquisitions, though its growth is modest and vulnerable to macroeconomic and geopolitical uncertainties.
Zacks·12d ago
News Placeholder
P/E Ratio Insights for Core Laboratories
read more...
Benzinga·18d ago
News Placeholder
Core Laboratories (CLB) Down 15.6% Since Last Earnings Report: Can It Rebound?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·24d ago
News Placeholder
Raiffeisen Bank International AG Sells 44,977 Shares of Core Laboratories Inc. $CLB
Raiffeisen Bank International AG cut its holdings in Core Laboratories Inc. (NYSE:CLB - Free Report) by 42.8% in the second quarter, according to the company in its most recent disclosure with the...
MarketBeat·25d ago
News Placeholder
Advisors Capital Management LLC Buys 36,196 Shares of Core Laboratories Inc. $CLB
Advisors Capital Management LLC boosted its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 15.2% during the second quarter, according to the company in its most recent Form 13F...
MarketBeat·29d ago
News Placeholder
Q4 EPS Forecast for Core Laboratories Boosted by Analyst
Core Laboratories Inc. (NYSE:CLB - Free Report) - Equities research analysts at Zacks Research boosted their Q4 2026 earnings per share (EPS) estimates for shares of Core Laboratories in a research...
MarketBeat·1mo ago
News Placeholder
What is Zacks Research's Forecast for CLB FY2025 Earnings?
Core Laboratories Inc. (NYSE:CLB - Free Report) - Equities research analysts at Zacks Research lifted their FY2025 EPS estimates for Core Laboratories in a research report issued to clients and...
MarketBeat·1mo ago
News Placeholder
Core Laboratories Q3 Earnings Surpass Estimates, Decline Y/Y
CLB beats Q3 earnings estimates on strong Production Enhancement results. However, earnings dip y/y due to the Reservoir Description segment's weakness.
Zacks·2mo ago
News Placeholder
Core Laboratories (CLB) Beats Q3 Earnings and Revenue Estimates
Core Laboratories (CLB) delivered earnings and revenue surprises of +15.79% and +5.50%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago

Latest CLB News

View

Advertisement|Remove ads.

Advertisement|Remove ads.